Literature DB >> 8488720

Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems.

M T Aguado.   

Abstract

The development of single-dose vaccines, mainly those administered during childhood, which would effectively protect against certain diseases, would be a very important advance towards better immunization coverage and protection against the respective pathogens. Biodegradable polymeric microspheres which are 'programmed' to deliver the antigen when a boost of the immune response is required, may be a possible way of achieving this goal.

Mesh:

Substances:

Year:  1993        PMID: 8488720     DOI: 10.1016/0264-410x(93)90241-o

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.

Authors:  M Singh; X M Li; H Wang; J P McGee; T Zamb; W Koff; C Y Wang; D T O'Hagan
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

2.  Stabilization of tetanus toxoid encapsulated in PLGA microspheres.

Authors:  Wenlei Jiang; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2008-08-19       Impact factor: 4.939

Review 3.  Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases.

Authors:  Chi-Ying Lin; Shih-Jie Lin; Yi-Chen Yang; Der-Yuan Wang; Hwei-Fang Cheng; Ming-Kung Yeh
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.

Authors:  A L Silva; P C Soema; B Slütter; F Ossendorp; W Jiskoot
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

5.  Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination.

Authors:  Rohiverth Guarecuco; Jennifer Lu; Kevin J McHugh; James J Norman; Lavanya S Thapa; Emily Lydon; Robert Langer; Ana Jaklenec
Journal:  Vaccine       Date:  2017-06-19       Impact factor: 3.641

6.  Immune Augmentation of Single Contact Hepatitis B Vaccine by Using PLGA Microspheres as an Adjuvant.

Authors:  S M Sivakumar; N Sukumaran; R Murugesan; T S Shanmugarajan; J Anbu; L Sivakumar; B Anilbabu; G Srinivasarao; V Ravichandran
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.